Pfizer/Allergan: An American Icon Heads For Greener (Tax) Pastures
This article was originally published in The Pink Sheet Daily
Pfizer and Allergan will combine in a deal valuing Allergan at $160bn and representing the largest corporate inversion ever. It is also the largest merger in the history of health care.
Register for our free email digests: